First-line combination therapy of immunotherapy plus anti-angiogenic drug for thoracic SMARCA4-deficient undifferentiated tumors in AIDS: a case report and review of the literature by Xiaoling Wei, Xiangju Xing, Wei Yao, Changzheng Wang, Yajie Xiao, Xianzhi Du

“…Considering that the weak immune status and intermediate PD-L1 level, the patient was treated with a first-line combination therapy of immunotherapy and anti-angiogenic drug instead of chemo-immunotherapy. …”
Get full text

The potential utility of phage therapy in the treatment of periprosthetic infection caused by multidrug-resistant pathogens: a review by Taalaibek U. Sheraliev, Alexander G. Samokhin, Baikozho R. Tashtanov, Andrey A. Korytkin, Vitaliy V. Pavlov

Subjects: “…phage-antibiotic combination therapy…”
Get full text

Comparative efficacy of clopidogrel-aspirin combination therapy versus aspirin monotherapy in preventing recurrent events in transient ischemic attack and minor stroke: a systematic review and meta-analysis by Ahmad Mujtaba Bhutto, Rana Ali Raza, Mohammad Bilal Abbasi, Iman Jauhar, Naeemullah Arbani, Muhammad Mubashir, Abdul Raheem, Taha Basit Ameen, Syed Muhammad Sinaan Ali

Get full text

Assessment of Clinical Analgesic Levels and Serum Biomarkers in Patients with Rheumatoid Arthritis: A Randomized Controlled Trial Comparing the Efficacy of Diclofenac and Methotrexate Combined Therapy with Extracorporeal Shockwave Therapy by Mei Zhang, Zhongyuan Ma, Rinkiko Suguro, Menglin Zhu, Esther Xinyi Chen, Xin Dong, Meixiu Chen, Linling Cheng, Bolun Su, Yizhun Zhu

Get full text

Effects of Clinicopathological Characteristics on the Survival of Patients Treated with PD-1/PD-L1 Inhibitor Monotherapy or Combination Therapy for Advanced Cancer: A Systemic Review and Meta-Analysis by Yuhan Wei, Yongfu Li, Qi Du, Xinyi Peng, Jiangtao Jin, Hong Guo, Yongyan Li, Qin Li

“…EGFR status for monotherapy and sex and smoking status for combination therapy were important predictors of survival benefits.…”
Get full text

Combination Therapy with 1% Nanocurcumin Gel and 0.1% Triamcinolone Acetonide Mouth Rinse for Oral Lichen Planus: A Randomized Double-Blind Placebo Controlled Clinical Trial by Mahin Bakhshi, Shahzad Gholami, Arash Mahboubi, Mahmoud Reza Jaafari, Mahshid Namdari

“…All patients received 0.1% triamcinolone mouth rinse and were then randomly divided into two groups for combination therapy with (I) %1 nanocurcumin gel or (II) placebo gel. …”
Get full text

Dynamics analysis and optimal control of a fractional-order lung cancer model by Xingxiao Wu, Lidong Huang, Shan Zhang, Wenjie Qin

Subjects: Get full text

Advantages of alginate and PPI combination in relief of heartburn and regurgitation during the first days of treatment of gastroesophageal reflux disease by D. S. Bordin, O. B. Yanova, O. I. Berezina, Ye. V. Treyman

Subjects: Get full text

Conversion therapy for unresectable intrahepatic cholangiocarcinoma using gemcitabine plus S-1 combined with PD-1 inhibitors: a case report by Shuangying Zhao, Xiaodong Zhang, Jialiang Luo, Huanjun Yan, Jianlei Zhang, Rongfeng Lin, Kelei Zhu

Subjects: Get full text

COMBINED TREATMENT OF LOCALLY-ADVANCED BLADDER CANCER by I. V. Chernyshev, Y. V. Samsonov, D. V. Perepechin, A. M. Ulbashev

Subjects: Get full text

Phytochemicals for mitigating the COVID-19 crisis: evidence from pre-clinical and clinical studies by Atri Das, Swarnali Khan, Syamal Roy, Shantanabha Das

Subjects: Get full text

Molecular Mechanisms of Synergistic Effect of PRIMA‐1met and Oxaliplatin in Colorectal Cancer With Different p53 Status by Xiao‐lan Li, Jianbiao Zhou, Nicole Xin‐Ning Tang, Yi Chai, Meng Zhou, Ai‐di Gao, Zhong‐kai Lu, Han Min

Subjects: Get full text

Targeting MYCN upregulates L1CAM tumor antigen in MYCN-dysregulated neuroblastoma to increase CAR T cell efficacy by Laura Grunewald, Lena Andersch, Konstantin Helmsauer, Silke Schwiebert, Anika Klaus, Anton G. Henssen, Teresa Straka, Marco Lodrini, Sebastian G. Wicha, Steffen Fuchs, Falk Hertwig, Frank Westermann, Alice Vitali, Carlotta Caramel, Gabriele Büchel, Martin Eilers, Kathy Astrahantseff, Angelika Eggert, Uta E. Höpken, Johannes H. Schulte, Thomas Blankenstein, Kathleen Anders, Annette Künkele

Subjects: Get full text

Charlson syndrome index predicted survival in pancreatic cancer patients received immunotherapy by Nan Zhang, Nan Zhang, Shiyun Chen, Yue Shi, Zhikuan Wang, Ru Jia, Guanghai Dai, Guanghai Dai

Subjects: Get full text

Current status of cytokine-induced killer cells and combination regimens in breast cancer by Yuancong Jiang, Jie Qiu, Nanwei Ye, Yingchun Xu

Subjects: Get full text

The effects of hyperbaric treatment on perianal fistula activity in patients with Crohn’s disease by Grażyna Piotrowicz, Jacek Kot, Andrzej Babicki, Piotr Banaszkiewicz, Adam Piotrowicz, Magdalena Rzeszutek, Agata Rudnik, Piotr Zientara, Joanna Adamska-Mieruszewska, Grażyna Rydzewska

Subjects: Get full text

Resveratrol-loaded metal-organic framework for mitochondria-targeted amplified CO gas therapy by Fengqin Wang, Yinfang Jiang, Yang Wang

Subjects: Get full text

Preoperative chemotherapy usage experience for intrahepatic cholangiocarcinoma by A. N. Polyakov, D. A. Granov, Yu. I. Patyutko, I. A. Pokataev, A. A. Polikarpov, T. I. Kagacheva, I. S. Bazin, A. Sh. Umirzokov, D. Yu. Frantsev, V. N. Zhuikov, D. V. Podluzhny

Subjects: Get full text

Dynamical properties and tumor clearance conditions for a nine-dimensional model of bladder cancer immunotherapy by K. E. Starkov, Svetlana Bunimovich-Mendrazitsky

Subjects: Get full text

War and peace: exploring microbial defence systems as a source of new antimicrobial therapies by Paul J. Dyson, Ibrahim M. Banat, Gerry A. Quinn

Subjects: Get full text